- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Middle East Respiratory Syndrome Coronavirus
Total 12923 results
-
King Abdullah International Medical Research CenterUniversity of OxfordCompletedMiddle East Respiratory Syndrome CoronavirusSaudi Arabia
-
National Institute of Allergy and Infectious Diseases...Naval Medical Research Center; SAb Biotherapeutics, Inc.CompletedMiddle East Respiratory Syndrome CoronavirusUnited States
-
Marylyn AddoCharite University, Berlin, Germany; University of Cologne; Ludwig-Maximilians... and other collaboratorsCompletedMERS (Middle East Respiratory Syndrome)Germany
-
King Abdullah International Medical Research CenterCompletedMiddle East Respiratory Syndrome Coronavirus (MERS-CoV)Saudi Arabia
-
Inovio PharmaceuticalsCoalition for Epidemic Preparedness InnovationsCompletedMiddle East Respiratory Syndrome Coronavirus (MERS-CoV)Lebanon, Jordan, Kenya
-
Universitätsklinikum Hamburg-EppendorfErasmus Medical Center; German Center for Infection Research; Coalition for Epidemic... and other collaboratorsActive, not recruitingMERS (Middle East Respiratory Syndrome)Germany, Netherlands
-
Gamaleya Research Institute of Epidemiology and...UnknownMERS (Middle East Respiratory Syndrome) | MERSRussian Federation
-
University of OxfordTerminatedMERS (Middle East Respiratory Syndrome)United Kingdom
-
Gamaleya Research Institute of Epidemiology and...Acellena Contract Drug Research and DevelopmentRecruitingMERS (Middle East Respiratory Syndrome) | MERSRussian Federation
-
National Research Centre, EgyptEgyptian Military Medical ServicesNot yet recruitingCOVID-19 | Coronavirus Infection | SARS-CoV 2 | Acute Respiratory Distress Syndrome | Corona Virus Infection | Middle East Respiratory Syndrome (MERS)Egypt
-
University of MinnesotaNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes...RecruitingInfluenza | Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV) | Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)United States, Australia, Spain, Denmark, Greece, Argentina, United Kingdom, Belgium, Chile, Germany, Peru, Thailand
-
FSD Pharma, Inc.TerminatedMast Cell Activation Syndrome | Mast Cell Activation Disorder IdiopathicCanada, United States
-
Pulmoquine Therapeutics, IncRockefeller UniversityCompletedSevere Acute Respiratory Syndrome Coronavirus 2United States
-
Vanderson Geraldo RochaTerminatedSARS-CoV2 | Severe Acute Respiratory Syndrome Coronavirus 2Brazil
-
University Hospital, Basel, SwitzerlandCompletedSevere-Acute-Respiratory-Syndrome-Coronavirus-2 (SARS-CoV-2)Switzerland
-
National Institute of Allergy and Infectious Diseases...Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN)CompletedCOVID-19 | SARS-CoV Infection | Allergic Reaction | Mast Cell DisorderUnited States
-
National Institute of Allergy and Infectious Diseases...Autoimmunity Centers of Excellence; Clinical Trials in Organ Transplantation...CompletedSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Disease 2019 (COVID-19) | Multisystem Inflammatory Syndrome in Children (MIS-C)United States
-
Gérond'ifCompletedSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)France
-
U.S. Army Medical Research and Development CommandNo longer availableTreatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP)Severe Acute Respiratory Syndrome Coronavirus 2United States, Germany, Afghanistan, Djibouti, Guam, Iraq, Japan, Kuwait
-
William Beaumont HospitalsCompletedCOVID-19 | Coronavirus Infection | Severe Acute Respiratory Syndrome Coronavirus 2United States
-
Elizabeth Glaser Pediatric AIDS FoundationFind; Kiambu CountyCompletedSevere Acute Respiratory Syndrome Coronavirus 2 InfectionKenya
-
AbbVieCompletedSevere Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2)United States
-
Ophirex, Inc.Premier Research Group plcTerminatedCoronavirus Disease 2019 | Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2United States
-
Saint Francis CareCompletedSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | COVID | CoronavirusUnited States
-
Grifols Therapeutics LLCTerminatedCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) InfectionSpain
-
AUVAParacelsus Medical UniversityCompletedCoronavirus Infection | SARS-CoV 2 | Covid19 | Severe Acute Respiratory Syndrome Coronavirus 2Austria
-
Walid HABRECompletedElectric Impedance | Severe Acute Respiratory Syndrome Coronavirus 2 | Prone PositioningSwitzerland
-
Apellis Pharmaceuticals, Inc.CompletedSevere Acute Respiratory Syndrome | Coronavirus Infection | Covid-19 | COVID | Acute Respiratory Distress Syndrome | Coronavirus | Ards | Severe Acute Respiratory Syndrome Coronavirus 2 | Sars-CoV2United States, Brazil
-
Inovio PharmaceuticalsAdvaccine (Suzhou) Biopharmaceuticals Co., Ltd.TerminatedSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Infection | COVID-19 DiseaseUnited States, Mexico, Colombia
-
National Institute of Allergy and Infectious Diseases...PPD; University of Washington; Vanderbilt University Medical Center; Implicit BioscienceTerminatedSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Disease 2019 (COVID-19)United States
-
Asan Medical CenterSuspendedCoronavirus Infection | Severe Acute Respiratory Syndrome Coronavirus 2 | Mild to Moderate COVID-19Korea, Republic of
-
Oneness Biotech Co., Ltd.CompletedDisease Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (Disorder)United States
-
Laboratorios Silanes S.A. de C.V.CompletedSevere Acute Respiratory Syndrome Coronavirus 2Mexico
-
Massachusetts General HospitalXijing Hospital; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico; Niguarda...CompletedCoronavirus | SARS (Severe Acute Respiratory Syndrome)United States, Sweden
-
Jordan Collaborating Cardiology GroupNot yet recruitingAortic Valve Stenosis | Severe Aortic Stenosis | ATTR Amyloidosis Wild Type | Middle East Studies
-
Goethe UniversityNationwide Network of University Medicine (NUM) on Covid-19RecruitingSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)Germany
-
Synairgen Research Ltd.CompletedCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2United Kingdom, Italy, United States, Portugal, Israel, Germany, Belgium, India, Spain, Netherlands, Argentina, Brazil, Colombia, France, Mexico, Romania, Serbia
-
Pontificia Universidad Catolica de ChileFundacion Arturo Lopez PerezCompletedSevere Acute Respiratory Syndrome Coronavirus 2Chile
-
Hospital Universitario San IgnacioPontificia Universidad Javeriana; Hospital Universitario Nacional de Colombia; Hospital de la Samaritana, Sede Bogotá y Sede Zipaquirá and other collaboratorsUnknownCOVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2
-
Sheng-Teng HuangCompletedCoronavirus Disease 2019 | Severe Acute Respiratory Syndrome Coronavirus 2 InfectionTaiwan
-
Hospices Civils de LyonCompletedSevere Acute Respiratory Syndrome Coronavirus 2 | Infection, CoronavirusFrance
-
Universidade do PortoInstituto Politécnico de BragançaEnrolling by invitationCoronavirus Infections | COVID-19 | SARS (Severe Acute Respiratory Syndrome) | Coronavirus Sars-AssociatedPortugal
-
University of Cape TownUniversity of KwaZuluUnknownSevere Acute Respiratory Syndrome Coronavirus 2South Africa
-
Azienda Ospedaliera Universitaria Integrata VeronaCharite University, Berlin, Germany; Institut National de la Santé Et de la... and other collaboratorsRecruitingCoronavirus Infections | Covid19 | Coronavirus Disease 2019 | Corona Virus Infection | Coronavirus | SARS-CoV2 Infection | COVID-19 Pneumonia | SARS-CoV-2 Acute Respiratory Disease | SARS (Severe Acute Respiratory Syndrome) | COVID-19 Respiratory Infection | SARS (Disease) | COVID-19 Acute Respiratory Distress... and other conditionsItaly, Belgium, Congo, France, Netherlands, Spain
-
University of SaskatchewanGovernment of Canada; Vaccine Formulation Institute (VFI); Government of Saskatchewan and other collaboratorsCompletedSevere Acute Respiratory Syndrome Coronavirus 2Canada
-
Blueprint Medicines CorporationRecruitingIndolent Systemic Mastocytosis | Monoclonal Mast Cell Activation SyndromeUnited States, Spain, Australia, France, Netherlands, Switzerland, Norway, United Kingdom, Austria, Belgium, Germany, Italy, Portugal
-
TakedaCompletedPrevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)Japan
-
University of SaskatchewanGovernment of Canada; Vaccine Formulation Institute (VFI); Government of Saskatchewan and other collaboratorsActive, not recruiting
-
University of SaskatchewanGovernment of Canada; Government of SaskatchewanWithdrawnSevere Acute Respiratory Syndrome Coronavirus 2
-
GT Biopharma, Inc.TerminatedAcute Myelogenous Leukemia | Systemic Mastocytosis | Mast Cell Leukemia | High-risk Myelodysplastic SyndromesUnited States